151 related articles for article (PubMed ID: 21086092)
1. Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.
Ali S; Yin-Goen Q; Johnson TV; Han W; Johnson NA; Harris WB; Marshall FF; Young AN; Master VA; Osunkoya AO
Tumour Biol; 2011 Apr; 32(2):375-80. PubMed ID: 21086092
[TBL] [Abstract][Full Text] [Related]
2. COX-2 Expression in Renal Cell Carcinoma and Correlations with Tumor Grade, Stage and Patient Prognosis.
Tabriz HM; Mirzaalizadeh M; Gooran S; Niki F; Jabri M
Asian Pac J Cancer Prev; 2016; 17(2):535-8. PubMed ID: 26925639
[TBL] [Abstract][Full Text] [Related]
3. VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value.
Dirim A; Haberal AN; Goren MR; Tekin MI; Peskircioglu L; Demirhan B; Ozkardes H
Int Urol Nephrol; 2008; 40(4):861-8. PubMed ID: 18324478
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
5. Relationship of CD95 and COX-2 in renal cell carcinomas with survival and other prognostic parameters: A tissue microarray study.
Erdem H; Aydin HR; Bahadir A; Gündogdu B; Balta H; Sener E; Kayikci MA; Albayrak A; Erdogan F
J Pak Med Assoc; 2015 Jun; 65(6):597-601. PubMed ID: 26060153
[TBL] [Abstract][Full Text] [Related]
6. Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.
Fu Q; Chang Y; Zhou L; An H; Zhu Y; Xu L; Zhang W; Xu J
Oncotarget; 2016 Feb; 7(7):8413-21. PubMed ID: 26716905
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
Tawfik OW; Kramer B; Shideler B; Danley M; Kimler BF; Holzbeierlein J
Arch Pathol Lab Med; 2007 Feb; 131(2):261-7. PubMed ID: 17284111
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.
Lamb GW; McArdle PA; Ramsey S; McNichol AM; Edwards J; Aitchison M; McMillan DC
BJU Int; 2008 Sep; 102(6):756-61. PubMed ID: 18384626
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J
Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211
[TBL] [Abstract][Full Text] [Related]
13. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
[TBL] [Abstract][Full Text] [Related]
15. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
[TBL] [Abstract][Full Text] [Related]
16. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO; Master VA
J Urol; 2011 Oct; 186(4):1213-7. PubMed ID: 21849188
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
18. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
[TBL] [Abstract][Full Text] [Related]
20. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
